This job is closed
Applications are no longer available for this announcement. Explore current related opportunities below.
Job description
This award winning regional non-profit health system is launching a groundbreaking 25-oncologist program, fueled by philanthropic investment and a dynamic collaboration with the University of Illinois system. This is a unique opportunity to shape the future of oncology through a robust focus on Phase 1 & 2 clinical trials.
Highlights
Medical Oncology or Hematology/Oncology position with ability to subspecialize exclusively in GI, Lung, GU, Malignant Hematology, Breast, or Head & Neck
Become a key contributor to Phase 1 & 2 clinical trials, with the potential for up to 40% research time
Optional academic faculty appointment, access to basic science lab, and partnering with University of Illinois system - the largest medical school system in the US
New $250 million, state-of-the-art cancer center with EPIC EMR
Salaries start at $650K for new grads + Generous Sign-On + Fellowship Stipends
Reasonable patient volumes with the autonomy to build the practice you want - 3-4 clinic days per week
Full health benefits, relocation assistance, CME allowance and PTO
About the Community
This vibrant community with a population of 1.7 mil is consistently ranking in the top 150 best metro areas to live in the US, offering affordability and a high quality of life. Perfectly positioned between St. Louis & Chicago for those quick getaways
History buffs love exploring the city's rich past, while art enthusiasts will appreciate the vibrant scene with theaters, music venues, and galleries. Families will find lots of kids activities and excellent public or private schools options
With its international airport, two universities and beautiful riverfront, it offers all the conveniences of a large college town in a friendly, welcoming atmosphere
#J-18808-Ljbffr
Worksite address
peoria, IL, 61639, US
Who can apply
Review the original listing for work authorization, qualifications and employer requirements.